Get started
Author

Marlene Langenbach

Observed name: Langenbach, Marlene
ORCID: 0009-0002-4679-5307
Observed ORCID: 0009-0002-4679-5307
OpenAlex ID: A5075546987
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
2022 · Jenny N. H. G. Ho, Dominik Schmidt, et al. · Blood · 58
PDF
Anti–PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation
2024 · Janaki Manoja Vinnakota, Rachael C. Adams, et al. · Science Translational Medicine · 38
PDF
Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease
2024 · Marie Czech, Sophia Schneider, et al. · Science Translational Medicine · 36
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells
2024 · Zhen Zhang, Marlene Langenbach, et al. · Nature Immunology · 35
MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
2023 · Marlene Langenbach, Sophie Giesler, et al. · Molecular Cancer Research · 34
PDF
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling
2025 · Alexander Zähringer, Inês Morgado, et al. · Blood Advances · 12
Supplementary Data from MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
2023 · Marlene Langenbach, Sophie Giesler, et al. · 1
Supplementary Data from MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
2026 · Marlene Langenbach, Sophie Giesler, et al.
Hybrid heterologous immunity shapes robust antiviral responses in children and minimizes age-related immunological differences
2026 · Roland Elling, Miriam Eisner, et al. · Research Square
PDF
Data from MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production
2024 · Marlene Langenbach, Sophie Giesler, et al.
Supplementary Data from MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production
2024 · Marlene Langenbach, Sophie Giesler, et al.
Supplementary Data from MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production
2024 · Marlene Langenbach, Sophie Giesler, et al.
MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production by melanoma cells
2024 · Langenbach, Marlene
PDF
Data from MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
2023 · Marlene Langenbach, Sophie Giesler, et al.
Supplementary Data from MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
2023 · Marlene Langenbach, Sophie Giesler, et al.
Supplementary Data from MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
2023 · Marlene Langenbach, Sophie Giesler, et al.
PDF
Data from MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
2023 · Marlene Langenbach, Sophie Giesler, et al.
Works count: 17
Citation count: 214
H-index: 6
I10-index: 6
Year
Topic
Type